semaglutide and local anesthesia Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement Outpatient Sedation Basics for Patients

According to Sarah McBane, PharmD, associate dean of pharmacy education at the University of California in Irvine, who specializes in womens health, the contraceptive warning specifically for tirzepatide may be because the medication is a dual agonist, meaning it acts on two gut hormones: glucagon-like peptide (GLP) and glucose-dependent insulinotropic polypeptide (GIP)

Tirzepatide 2.5 mg activates both GLP-1 and GIP receptors, while semaglutide 0.25 mg activates only GLP-1 receptors

Semaglutide offers many benefits for patients seeking weight loss

Silva R, Carrageta DF, Alves MG, Silva BM, Oliveira PF

Research demonstrates that: Men taking semaglutide showed higher rates of testosterone deficiency (3.83%) compared to those not taking the medication (1.7%) The medication influences GLP-1 hormone levels, which affects various metabolic processes Hormonal changes may be more pronounced during initial weight loss periods [12] Important Considerations for Hormone Function: Weight loss achieved through Wegovy may lead to positive hormonal adjustments

Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V